Miriam Grazia Ferrara
0000-0002-3678-2599
4 papers found
Refreshing results…
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned
Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
Missing publications? Search for publications with a matching author name.